United Therapeutics Corp (NASDAQ: UTHR) reported Q4 EPS of $0.79, $0.08 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $195.2 million versus the consensus estimate of $204.81 million.

United Therapeutics Corp reaffirmed FY2012 guidance.

For earnings history and earnings-related data on United Therapeutics Corp (UTHR) click here.

Earnings